Uncovering the Role of Thrombospodin-1 and Occludin as Potential Prognostic and Diagnostic Biomarkers in Traumatic Brain Injury
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Céline Decouty-Pérez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Instituto de Investigación Sanitaria-Princesa IIS-IP, Hospital Universitario…. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Occludin, Thrombospondin 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Traumatic brain injury (TBI) is a highly heterogeneous disease and achieving an accurate diagnosis remains a significant challenge. Biomarkers play a crucial role in minimizing the reliance on invasive techniques like computed tomography, which also have significant economic costs. Human samples were obtained from prospective cohort studies. Mice were subjected to an experimental model of traumatic brain injury. Biomarker levels, gene expression, and blood–brain barrier integrity were analyzed using ELISA, qRT-PCR, and Evans Blue assay; data were statistically evaluated using parametric or non-parametric tests as appropriate. This study focuses on evaluating the role of matricellular protein thrombospondin-1 (TSP-1) and the tight junction proteins occludin and ZO-1 as potential biomarkers of TBI. We showed that lower serum TSP-1 levels correlated with poor patient outcomes at 6 months compared to those patients with a good outcome. Additionally, the disruption of the blood–brain barrier (BBB) and subsequent release of tight junction proteins allowed us to identify occludin as a potential biomarker for prognosis in a cohort of TBI patients and as a diagnosis biomarker in a subgroup of patients with mild TBI, but its discriminative power as a diagnosis biomarker appears modest, as reflected by an AUC of 0.693. On the other hand, ZO-1 exhibited increased levels but limited diagnostic utility. These findings highlight the critical role of TSP-1 in maintaining BBB integrity and regulating the inflammatory response after a TBI, supported by the worsened condition observed in TSP-1-deficient animals. These results demonstrate the potential of TSP-1 and occludin as valuable biomarkers for secondary injury and disease progression in patients with mild to moderate/severe TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Instituto de Investigación Sanitaria-Princesa IIS-IP, Hospital Universitario Santa Cristina, 28009 Madrid, Spain.
- Department of Medicine, School of Medicine, Universidad Autónoma of Madrid, 28029 Madrid, Spain.
- Instituto Investigación Sanitaria-Princesa IIS-IP, 28006 Madrid, Spain.
- Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
- Department of Neurology, Hospital Universitario Virgen Macarena, 41004 Sevilla, Spain.
- Service of Neurosurgery, Hospital Universitario La Paz, 28029 Madrid, Spain.
ORCID-Profile: Inés Valencia, Víctor Farré-Alins, María J Calzada, Joan Montaner, Mario Taravilla-Loma, Borja J Hernández-García, Águeda González-Rodríguez, Ana Belen Lopez-Rodriguez, Javier Egea
Förderung
- CSRD VA
- Instituto de Salud Carlos III
- Ministerio de Ciencia, Innovación y Universidades
- Fundación Mutua Madrileña and Fondo de Investigaciones Sanitarias (FIS)
Zitieren
APA
Decouty-Pérez, C., Valencia, I., Alvarez-Rubal, M., Martínez-Cuevas, E., Farré-Alins, V., Calzada, M. J., Penalba, A., Montaner, J., Rodríguez de Cía, J., Taravilla-Loma, M., Hernández-García, B. J., Fuertes-Yebra, E., González-Rodríguez, Á., Lopez-Rodriguez, A. B., & Egea, J. (2026). Uncovering the Role of Thrombospodin-1 and Occludin as Potential Prognostic and Diagnostic Biomarkers in Traumatic Brain Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020571
Vancouver
Decouty-Pérez C, Valencia I, Alvarez-Rubal M, Martínez-Cuevas E, Farré-Alins V, Calzada MJ, et al. Uncovering the Role of Thrombospodin-1 and Occludin as Potential Prognostic and Diagnostic Biomarkers in Traumatic Brain Injury. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020571
BibTeX
@article{DecoutyPrez2026,
author = {Decouty-Pérez, Céline and Valencia, Inés and Alvarez-Rubal, María and Martínez-Cuevas, Elena and Farré-Alins, Víctor and Calzada, María J and Penalba, Anna and Montaner, Joan and Rodríguez de Cía, Javier and Taravilla-Loma, Mario and Hernández-García, Borja J and Fuertes-Yebra, Esther and González-Rodríguez, Águeda and Lopez-Rodriguez, Ana Belen and Egea, Javier},
title = {Uncovering the Role of Thrombospodin-1 and Occludin as Potential Prognostic and Diagnostic Biomarkers in Traumatic Brain Injury},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020571}
}
EUVIMED